Back to School: How biopharma can reboot drug development. Access exclusive analysis here
By licensing balsalazide from Salix Pharmaceuticals Ltd., Shire Pharmaceuticals Group plc now has two products to treat ulcerative colitis. SHP already owns U.S. rights to Pentasa as
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury